| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 大健康产品(元) | 546,095.67 | 3,720,051.22 | 3,143,355.82 | 5,452,002.94 | 3,776,829.30 |
| 医药制造和销售(元) | 452,822,877.23 | 973,937,117.25 | 495,494,783.55 | 965,504,941.23 | 425,780,468.22 |
| 其他(元) | 1,987,660.85 | 3,170,935.88 | 1,380,234.44 | 3,336,191.32 | 1,417,350.61 |
| 营业成本(元) | |||||
| 大健康产品(元) | - | 2,156,514.81 | - | 2,371,388.15 | - |
| 医药制造和销售(元) | 169,478,465.73 | 409,123,241.53 | 223,785,361.55 | 404,544,842.74 | 186,280,856.49 |
| 其他(元) | - | 1,465,877.29 | - | 1,092,791.49 | - |
| 毛利(元) | |||||
| 大健康产品(元) | - | 1,563,536.41 | - | 3,080,614.79 | - |
| 医药制造和销售(元) | 283,344,411.50 | 564,813,875.72 | 271,709,422.00 | 560,960,098.49 | 239,499,611.73 |
| 其他(元) | - | 1,705,058.59 | - | 2,243,399.83 | - |
| 毛利率(%) | |||||
| 大健康产品(%) | - | 42.03 | - | 56.50 | - |
| 医药制造和销售(%) | 62.57 | 57.99 | 54.84 | 58.10 | 56.25 |
| 其他(%) | - | 53.77 | - | 67.24 | - |
| 收入构成(%) | |||||
| 大健康产品(%) | 0.12 | 0.38 | 0.63 | 0.56 | 0.88 |
| 医药制造和销售(%) | 99.44 | 99.30 | 99.10 | 99.10 | 98.79 |
| 其他(%) | 0.44 | 0.32 | 0.28 | 0.34 | 0.33 |
| 毛利构成(%) | |||||
| 大健康产品(%) | 0.00 | 0.28 | 0.00 | 0.54 | 0.00 |
| 医药制造和销售(%) | 100.00 | 99.42 | 100.00 | 99.06 | 100.00 |
| 其他(%) | 0.00 | 0.30 | 0.00 | 0.40 | 0.00 |